eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

GlaxoSmithKline Consumer Healthcare

980 Great West Road, Brentford, Middlesex, TW8 9GS
Telephone: +44 (0)20 8047 5000
Medical Information Direct Line: +44 (0)20 8047 2500
Medical Information e-mail: customer.relations@gsk.com
Customer Care direct line: +44 (0)20 8047 2700
Medical Information Fax: +44 (0)20 8047 6860

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 17/03/2011
SPC Alphosyl HC Cream


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Alphosyl HC Cream


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Allantoin

2.0% w/w

Alcoholic Extract of Coal Tar

5.0% w/w

Hydrocortisone

0.5%


Go to top of the page
3. PHARMACEUTICAL FORM

Cream for topical application.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the treatment of psoriasis by topical administration.


Go to top of the page
4.2 Posology and method of administration

For all patients, apply cream sparingly twice daily to psoriatic plaques - rub in well until the cream is no longer visible.

Not recommended for children under 5 years.


Go to top of the page
4.3 Contraindications

Tuberculosis or fungal lesions of the skin (e.g. athlete's foot), acne vulgaris, herpes simplex (cold sores), vaccinia or varicella, and a history of hypersensitivity to any of the ingredients.

Not for use in sore, acute or pustular psoriasis or in the presence of infection.


Go to top of the page
4.4 Special warnings and precautions for use

For external use only.

Avoid contact with the eyes. Avoid mucosa, genital or rectal areas and broken or inflamed skin.

Use sparingly, discontinue use if sensitivity occurs.

The following results of steroid use are uncommon at this dosage

However:

- When used over large areas or for prolonged periods systemic side effects can result.

- Under occlusive dressings or intertriginous areas topical steroids may cause skin atrophy manifesting as striae, thinning and telangiectesia.

- Viral, bacterial or fungal infection of the skin may be substantially exacerbated by topical steroid treatment unless accompanied by appropriate therapy.

- Wound healing can be significantly retarded.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None


Go to top of the page
4.6 Pregnancy and lactation

Topical administration of corticosteroids to pregnant animals can cause abnormality of foetal development. Topical steroids should not be used extensively during pregnancy, i.e. in large amounts or for long periods because of the risk of teratogenic effects or significant absorption causing suppression of the HPA axis.


Go to top of the page
4.7 Effects on ability to drive and use machines

None


Go to top of the page
4.8 Undesirable effects

Adverse events derived from post-marketing data are tabulated below by system organ class. The frequency of these adverse events is not known (cannot be estimated from the available data).

Body System

Undesirable effect

Immune system disorders

Hypersensitivity (including rash, itching, dyspnoea and angioedema)

Allergic reactions*

Skin and subcutaneous tissue disorders

Skin irritation and acne like eruptions

Photosensitivity

*Allergic reactions may be delayed.


Go to top of the page
4.9 Overdose

Not applicable


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Coal tar is a standard antipruritic and keratoplastic agent used in the treatment of psoriasis and other skin affections.

Allantoin is a chemical dedrider; stimulates cell proliferation, epithelization and granulation, and hence hastens wound healing.

Steroids are standard in the treatment of various skin disorders.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable


Go to top of the page
5.3 Preclinical safety data

Several animal studies have demonstrated that the non-carcinogenic toxicity profile of medicinal coal tar is acceptable.

Coal tar preparations have been shown to contain chemicals with a known relationship to the development of malignant tumours in experimental models. Animal studies, where coal tar has been applied topically, have consistently given positive results.

However, it is consistently clear that epidemiological studies in man have not confirmed this carcinogenic potential. Where isolated case studies have related the use of medicinal coal tar to tumour induction, well controlled retrospective studies have not confirmed the relationship. The individual case reports are not well documented as to causation.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Beeswax Yellow

Cetyl Alcohol

Citric Acid

Maize Oil

Glycerol Monostearate

Isopropyl Palmitate

Liquid Base CB 3929

Methyl Hydroxybenzoate

Oleyl Alcohol

Propyl Gallate

Propyl Hydroxybenzoate

PEG-400 Dilaurate

Sodium Citrate

Sqaulene

Lecithin, Vegetable

Triethanolamine

Phenethyl Alcohol

Water Purified


Go to top of the page
6.2 Incompatibilities

None known


Go to top of the page
6.3 Shelf life

18 months


Go to top of the page
6.4 Special precautions for storage

Store between 4°C and 25°C


Go to top of the page
6.5 Nature and contents of container

Alphosyl HC Cream is packaged in decorated, 30 g or 100 g collapsible aluminium tubes with a phenolic/epoxy resin liner and latex end seal. The nozzle is closed with a high density polyethylene screw on cap.


Go to top of the page
6.6 Special precautions for disposal and other handling

For all patients, apply sparingly twice a day to psoriatic plaques and rub in well until the cream is no longer visible. Alphosyl HC Cream is not recommended for children under 5 years.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Stafford-Miller Limited

980 Great West Road

Brentford, Middlesex

TW8 9GS

United Kingdom

Trading as: GlaxoSmithKline Consumer Healthcare, Brentford TW8 9GS, UK


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00036/0026R


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

17/1/1997


Go to top of the page
10. DATE OF REVISION OF THE TEXT

11/03/2011



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/13756/SPC/


Active Ingredients/Generics

 
   hydrocortisone
   coal tar extract
   allantoin